ONCOTARTIS
OncoTartis, Inc. is a private biotechnology company established in 2011. Company’s founding IP came from Prof. Andrei Gudkov’s laboratory at Roswell Park Cancer Institute (Buffalo, NY). OncoTartis develops a novel category of anti-cancer drugs directed against tissue-specific targets for a subset of cancers (breast, prostate, ovarian, melanoma and hematological malignancies). Its leading product OT-82 is a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor being developed to treat Acute Myeloid Leukemia (AML). Investigational New Drug application (IND) will be submitted to FDA in the forth quarter of 2017.
ONCOTARTIS
Industry:
Biometrics Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.oncotartis.com
Total Employee:
1+
Status:
Active
Contact:
716.858.3055
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome AJAX Libraries API Gravatar Profiles WooCommerce Wordpress 4.6
Similar Organizations
AmStem
AmStem operates as a biotechnology company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Dignitek Health technologies
A MED technology company
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Geneius
Geneius is a Biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
The Shockbox
A privately-held wearable technology compan.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Pharmstandard International
Pharmstandard International investment in Venture Round - OncoTartis
Millhouse
Millhouse investment in Venture Round - OncoTartis
Official Site Inspections
http://www.oncotartis.com Semrush global rank: 6.04 M Semrush visits lastest month: 1.35 K
- Host name: 91.195.240.13
- IP address: 91.195.240.13
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "OncoTartis"
OncoTartis, Inc. - LinkedIn
OncoTartis, Inc. is a private biotechnology company established in 2011. It is located at the Thomas R. Beecher Innovation Center on Buffalo Niagara Medical Campus.See details»
OncoTartis, Inc. Information - RocketReach
OncoTartis, Inc. is a private biotechnology company established in 2011. It is located at the Thomas R. Beecher Innovation Center on Buffalo Niagara Medical Campus. It has a strategic …See details»
OncoTartis Company Profile 2024: Valuation, Funding & Investors
OncoTartis General Information Description. Developer of anti-cancer drugs designed to help patients recover from acute leukemia. The company's drug development approach is designed …See details»
Oncotartis, Inc. Company Profile | Buffalo, NY | Competitors ...
Find company research, competitor information, contact details & financial data for Oncotartis, Inc. of Buffalo, NY. Get the latest business insights from Dun & Bradstreet.See details»
OncoTartis, Inc. - Company Profile & Staff Directory - ContactOut
OncoTartis, Inc. is a private biotechnology company established in 2011. It is located at the Thomas R. Beecher Innovation Center on Buffalo Niagara Medical Campus. It has a strategic …See details»
OncoTartis, Inc. Overview | SignalHire Company Profile
OncoTartis, Inc. is a private company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Biotechnology areas ... Organization Website: …See details»
OncoTartis - The Org
OncoTartis, Inc.'s mission is to revolutionize the treatment of a subset of cancers (breast, prostate, ovarian, melanoma, and hematological malignancies) by developing a novel category …See details»
OncoTartis - Overview, News & Similar companies | ZoomInfo.com
Who is OncoTartis. About OncoTartis: OncoTartis, Inc. (www.oncotartis.com) is a private biotechnology company established in 2011. The Company's founding IP came from the …See details»
OncoTartis - Products, Competitors, Financials, Employees, …
OncoTartis is a private biotechnology company focused on developing a novel category of anti-cancer drugs targeting tissue-specific vulnerabilities in various cancers. The company's main …See details»
OncoTartis - Company Profile - Tracxn
Nov 27, 2024 OncoTartis - Using small molecule against tissue-specific targets for a subset of cancers. Raised a total funding of $14.2M over 4 rounds from 4 investors. Founded by …See details»
OncoTartis Company Profile - Office Locations, Competitors ... - Craft
OncoTartis has 5 employees at their 1 location and $6 m in total funding,. See insights on OncoTartis including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
OncoTartis, Inc. - VentureRadar
OncoTartis, Inc. is a private biotechnology company established in 2011. Company’s founding IP came from Prof. Andrei Gudkov’s laboratory at Roswell Park Cancer Institute (Buffalo, NY). …See details»
OncoTartis' Leadership Team - Team members and org chart - The …
The leadership team at OncoTartis has a long history of experience in the biotech industry, with a focus on cancer research and development. The team includes a CEO who was previously at …See details»
OncoTartis' CEO and Executive Team - Team members and org …
The executive team at OncoTartis has a history of experience in the biotech industry and pharmaceutical research. The team includes a venture partner from Maxwell Biotech Venture …See details»
OncoTartis Company Profile | Management and Employees List
Find contact information for OncoTartis. Learn about their Business Services market share, competitors, and OncoTartis's email format.See details»
OncoTartis - Contacts, Employees, Board Members, Advisors
A private biotechnology company.See details»
OncoTartis, Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... OncoTartis, Inc. is a private …See details»
OncoTartis LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore OncoTartis LLC with its drug pipeline, therapeutic area, technology platform, , Drug:OT-82.See details»
Oncotartis, Inc. (Oncotartis, Inc.) - 药物管线_专利_临床试验_投融营 …
项与 Oncotartis, Inc. 相关的文献（医药） 2020-07-01 · Leukemia 1区 · 医学 OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies …See details»
Canadian health plans, pharma firm agree on terms to fund costly ...
2 days ago An organization representing Canada's public drug plans has come to a deal with a pharmaceutical company over a cutting-edge means of treating prostate cancer, bringing …See details»